ASH is Continuing Its Advocacy to Protect Vulnerable Children
American Society of Hematology (ASH) shared a post on LinkedIn:
“The American Society of Hematology is continuing its advocacy to protect vulnerable children. After submitting comments to the CDC’s Advisory Committee on Immunization Practices (ACIP) in September, ASH has reinforced its message ahead of the December meeting:
➡ Maintain the current child and adolescent immunization schedule.
➡ Preserve Hepatitis B vaccine protocols.
Children with hematologic conditions—such as sickle cell disease, leukemia, hemophilia, and other blood disorders—are immunocompromised and face heightened risks from infections that vaccines can prevent. Vaccines are not just preventive; they are lifesaving.
Read the full comment”
Get the latest from Hemostasis Today.
-
Nov 29, 2025, 17:37Almahdi Ali Explores Ipsilateral Paradoxical Thromboembolism at 22nd European Angiology Days 2025
-
Nov 29, 2025, 17:23Jack Shuang Hou Shares Major Neurology Updates This Week
-
Nov 29, 2025, 16:52Federica Fogacci on Further Strengthening Collaboration Within the Lp(a)CCELERATE Study
-
Nov 29, 2025, 16:42Dr Abdul Mannan on the Echinocyte: Mastering the Diagnostic Duality of Artifact vs. Pathology
-
Nov 29, 2025, 16:42Vikas Dua: Heme Next 1.0 A Conference with a Difference
-
Nov 29, 2025, 16:41Hind Ali: Sources Of Error in Cell Counts
-
Nov 29, 2025, 16:40Maxime Dely: Even on a Break, You Can Give
-
Nov 29, 2025, 16:39Shrinidhi Nathany: HemeNext Brings Science, Technology, and Leadership Together
-
Nov 29, 2025, 16:38PF4 Antibody Persistence and Long-term Pathogenicity in VITT